Page last updated: 2024-10-27

fluorouracil and Coagulation Disorders, Blood

fluorouracil has been researched along with Coagulation Disorders, Blood in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"A total of 18 colorectal cancer patients who received bevacizumab combined with chemotherapy were included."1.38Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography. ( Akay, OM; Bal, C; Gulbas, Z; Keskin, M; Kuş, E; Ustuner, Z, 2012)
" Twelve were on an average warfarin dosage of 19."1.33A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin. ( Diasio, R; Ledbetter, L; Saif, MW; Shah, HR, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ustuner, Z1
Akay, OM1
Keskin, M1
Kuş, E1
Bal, C1
Gulbas, Z1
Shah, HR1
Ledbetter, L1
Diasio, R1
Saif, MW1

Other Studies

2 other studies available for fluorouracil and Coagulation Disorders, Blood

ArticleYear
Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography.
    Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:5

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bloo

2012
A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.
    Clinical colorectal cancer, 2006, Volume: 5, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antimetabolites, Antineoplastic; Blood Coagulation D

2006